Review Article

The Role of Type 3 Diabetes in Alzheimer’s Disease: A Review of Current Evidence

Table 1

Eligibility Criteria

Criteria Inclusion Exclusion

Language All articles published in English. Non-English articles and publications.
Publication Date Articles published within the last 10 years (2014–2024). Articles published more than 10 years ago.
Peer Review Articles and publications that are peer-reviewed. Articles and publications that are not peer-reviewed, news articles, editorials, letters, and commentaries.
Focus on Diabetes Patients diagnosed with Diabetes. Patients not diagnosed with Diabetes.
Focus on Alzheimer’s Disease Patients diagnosed with Alzheimer’s Disease (AD). Patients not diagnosed with Alzheimer’s Disease (AD).
Age Range Patients in age ranges typically associated with the onset and progression of T2DM and AD (middle-aged to elderly). Not applicable or not meeting the age-related criteria for T2DM and AD.
Study Focus Articles investigating the concept of “Type 3 Diabetes” in relation to AD. Articles addressing AD with other neurological/psychiatric conditions (e.g., schizophrenia, bipolar, TBI).
Comorbidities N/A Patients with severe comorbidities (e.g., ESRD, CHF, active malignancies).
Medication Use N/A Patients using medications affecting cognition or glucose regulation (e.g., antidepressants, glucocorticoids).
General Criteria Articles that meet all inclusion criteria. Articles that do not meet the inclusion criteria.